Month: May 2021

Herbs have been used in medicine for many years, and their powers are only becoming more recognised in the Western world. From infusions to decoctions and tinctures, there are many ways to introduce herbs into our daily lives. Plants and mushrooms have been used traditionally in many cultures for their healing qualities. Herbalists have been
0 Comments
The American Association of Clinical Endocrinology (AACE) has issued its first-ever official guidelines addressing the use of advanced technologies in the management of people with diabetes. The guidelines cover use of continuous glucose monitoring (CGM), insulin pumps, connected pens, automated insulin delivery systems, telemedicine technologies, and smartphone apps. They also address safety considerations, special situations
0 Comments
Identifying markers that indicate severe COVID-19 disease trajectories could lead to early medical interventions and help reduce morbidity and mortality. In a new study posted to the bioRxiv* preprint server, a prospective cohort of patients with COVID-19 exhibited distinct features of the IgG fragment antigen-binding (Fab) and fragment crystallizable (Fc) domains, predicting two distinct disease
0 Comments
FDA Approves Truseltiq (infigratinib) for the Treatment of Cholangiocarcinoma PALO ALTO, Calif. and LUGANO, Switzerland, May 28, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), through its affiliate QED Therapeutics, Inc., and Helsinn Group today announced that the US Food and Drug Administration (FDA) has approved Truseltiq (infigratinib) under the accelerated approval program for
0 Comments
Lee Hsien Loong, Singapore’s prime minister. Roslan Rahman | AFP | Getty Images SINGAPORE — Singapore’s Prime Minister Lee Hsien Loong said Monday that the country’s Covid restrictions may be relaxed after June 13 if the situation improves. “Barring another super-spreader or big cluster, we should be on track to bring this outbreak under control,”
0 Comments
It felt like my head was in a vice. That’s how some people describe the pain of a migraine. But a migraine is much more than just a headache. It includes symptoms that happen before the pain starts and after it goes away. One of those symptoms is aura, and it can be just as
0 Comments
Another randomized trial has compared two common approaches to stenting complex and challenging left-main (LM) coronary bifurcation lesions, and this one showed little difference between the strategies on clinical outcomes at 1 year. Both types of intervention worked well, procedurally and in terms of symptoms, researchers said. But “stepwise, provisional stenting” used fewer stents and other
0 Comments
Putting ourselves into another’s shoes might seem simple to some, but for others it’s no walk in the park. Here, we explore the two ends of the empathy scale Possessing empathy is a significant human capability that allows us to connect with one another, as well as to recognise, understand, and share a range of
0 Comments
Treatment with sotrovimab resulted in an 85% reduction in the risk of hospitalization or death in high-risk adult outpatients compared to placebo, based on interim results from Phase 3 COMET-ICE trial In vitro data indicate sotrovimab maintains activity against all known variants of concern, including the variant from India Sotrovimab will be available for appropriate
0 Comments
FDA Approves Pylarify (piflufolastat F 18) PSMA-Targeted PET Imaging Drug for Men with Prostate Cancer May 27, 2021 — FDA has approved Pylarify (piflufolastat F 18) – a drug for positron emission tomography (PET) imaging of prostate-specific membrane antigen (PSMA) positive lesions in men with prostate cancer. With the approval of Pylarify, certain men with prostate
0 Comments
Reunions are on the horizon, but what is it about social bonds that makes them run so deep? Family means something different to all of us. For some, it’s nuclear, for others it’s blended, adopted, or chosen. Our friends also join us in our inner circles, standing with us through the good and bad –
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Gastrointestinal symptoms and chronic fatigue may persist months after the COVID-19 virus infection resolves, results of a recent cohort-controlled study suggest. About 5 months after SARS-CoV-2 infection, relative risks of loose stools, somatization, and chronic fatigue were increased by approximately two-
0 Comments
SER-109, an oral microbiome therapeutic, safely protects against Clostridioides difficile recurrence for up to 24 weeks, according to a recent phase 3 trial. Three days of treatment with purified Firmicutes spores reduced risk of recurrence by 54%, suggesting a sustained, clinically meaningful response, according to a multicenter study presented at this year’s Digestive Disease Week® (DDW). “Antibiotics targeted
0 Comments
The La Jolla Institute for Immunology (LJI) is partnering with Synbal, Inc., a preclinical biotechnology company based in San Diego, CA, to develop multi-gene, humanized mouse models for COVID-19 research. The research at LJI will be led by Professor Sujan Shresta, Ph.D., a member of the Institute’s Center for Infectious Disease and Vaccine Research. “With
0 Comments
FDA Approves Lumakras (sotorasib) for KRAS G12C-Mutated Locally Advanced Or Metastatic Non-Small Cell Lung Cancer THOUSAND OAKS, Calif., May 28, 2021 /PRNewswire/ — Amgen (NASDAQ: AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) for the treatment of adult patients with KRAS G12C-mutated locally advanced or metastatic non-small cell
0 Comments
In April we marked World Health Day, a World Health Organization (WHO) celebration that began in 1950. This year’s theme calls for building a fairer, healthier world for everyone.  It shines a tragic spotlight on the struggle for equity and the health inequities minorities face, especially with COVID-19. The lessons of COVID According to the
0 Comments